Airbus completes first SIRTAP prototype assembly; prepares for ground tests

Michael Schoellhorn Chief Executive Officer Airbus Defence and Space Airbus SE
Michael Schoellhorn Chief Executive Officer Airbus Defence and Space - Airbus SE
0Comments

The first prototype of Airbus’ SIRTAP, a tactical uncrewed aerial system, has completed assembly and is set to begin ground tests at the Airbus Defence and Space facilities in Getafe, Spain. The testing phase will include structural evaluations, main systems components, and software testing over the coming months. The maiden flight is planned for late 2025 at Spain’s National Institute of Aerospace Technology’s Unmanned Systems Test Centre (CEUS) in Huelva.

Following this, a comprehensive flight-test campaign at CEUS throughout 2026 aims to secure airworthiness type certification. This process ensures that the aircraft adheres to high safety and performance standards before its anticipated delivery to Spain in 2027.

Jean-Brice Dumont, Head of Air Power at Airbus Defence and Space, commented on the achievement: “This new technical achievement for SIRTAP demonstrates Airbus’ agility to drive technological innovation with our aerospace industry partners in a timely manner in accordance with our vision.” He further emphasized that SIRTAP would enhance national sovereignty and set a benchmark in tactical unmanned aerial systems globally.

In November 2023, the Spanish Ministry of Defence procured nine systems comprising three remotely-piloted aircraft each and a ground-control station. This acquisition will bolster the Spanish Armed Forces’ tactical capabilities with a total of 27 drones and nine ground-control stations. Additionally, Airbus Defence and Space will provide two simulators for operator training following the completion of their architecture and design through the Critical Design Review.

SIRTAP underscores a strategic commitment to innovation and industrial collaboration within Spain while offering an exportable platform due to its ITAR-free design. Future developments may include naval versions or weapons integration, contributing further to industrial capabilities in remotely-piloted vehicles.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.